WAGO 2026 Oral Abstract Presentations
Abstract #1
Thursday, June 18, 2026 | 8:10 am – 8:25 am
A cohort study assessing the impact of glucagon-like peptide-1 receptor agonist use on BMI and weight loss for patients with endometrial intraepithelial neoplasia and low-grade endometrial cancer.
Presented by Varun Khetan, MD, LAG Medical Center / Keck Hospital
Learn MoreAbstract #2
Thursday, June 18, 2026 | 8:25 am – 8:40 am
Actionable Genomic Alterations in Homologous Recombination–Proficient Ovarian Cancer
Presented by Jordan Shin, MD, University of California Los Angeles
Learn MoreAbstract #3
Thursday, June 18, 2026 | 8:40 am – 8:55 am
Uncovering critical steps of T cell activation in immune checkpoint inhibitor therapy (ICI) in high microsatellite instability (MSI-H) endometrial cancer (EC)
Presented by Danielle Greenberg, MD, University of California, Irvine
Learn MoreAbstract #4
Thursday, June 18, 2026 | 8:55 am – 9:10 am
Endometrial cancer survivors can improve function with remote behavioral intervention: Results from RISE
Presented by Anusha Adkoli, MD, Mayo Clinic
Learn MoreAbstract #5
Thursday, June 18, 2026 | 9:10 am – 9:25 am
Characteristics of abnormal uterine bleeding (AUB) in pre-menopausal adult patients with obesity
Presented by Prianca Ramanan, MD, MS, UCSF / Kaiser Permanente San Francisco
Learn MoreAbstract #6
Thursday, June 18, 2026 | 10:00 am – 10:15 am
Second look laparoscopy after frontline therapy in advanced ovarian cancer: Updated clinical outcomes
Presented by Anne Knisely, MD, The University of Texas MD Anderson Cancer Center
Learn MoreAbstract #7
Thursday, June 18, 2026 | 10:15 am – 10:30 am
Epithelial intra-tumoral heterogeneity in ovarian cancer resistance to anti-angiogenic therapy
Presented by Amma Asare, MD Anderson Cancer Center
Learn More
Abstract #8
Thursday, June 18, 2026 | 10:30 am – 10:45 am
Antibody drug conjugate target expression profiling in tubo-ovarian high grade serous carcinoma (HGSC)
Presented by Lindsey Finch, MD, Stanford University
Learn MoreAbstract #9
Thursday, June 18, 2026 | 10:45 am – 11:00 am
Mucinous ovarian cancer disproportionately drives racial survival inequity: a population-based SEER analysis
Presented by Joseph Lafferty, MD, Cedars Sinai
Learn MoreAbstract #10
Thursday, June 18, 2026 | 11:00 am – 11:15 am
Prescribing Patterns and Uptake of Hormone Replacement Therapy in Premenopausal Women Following Bilateral Oophorectomy for Borderline Ovarian Tumors
Presented by Chinmayi Aryasomayajula, MD, University of California, Los Angeles
Learn MoreAbstract #11
Friday, June 19, 2026 | 8:15 am – 8:30 am
Implementation and Early Outcomes of HPV Self-Collection in a Safety-Net Health System
Presented by Leane Nasrallah, MD, MPH, University of California, Los Angeles
Learn MoreAbstract #12
Friday, June 19, 2026 | 8:30 am – 8:45 am
The coverage gap: The impact of economic factors on the utilization of standard-of-care brachytherapy in locally advanced cervical cancer
Presented by Ananya Murthy, BS, The University of Texas at Austin Dell Medical School
Learn MoreAbstract #13
Friday, June 19, 2026 | 8:45 am – 9:00 am
Treatment of locally advanced cervical and vaginal cancer with INTERLACE protocol in a real-world patient population
Presented by Lauren Falk, MD, University of Oklahoma Stephenson Cancer Center
Learn MoreAbstract #14
Friday, June 19, 2026 | 9:00 am – 9:15 am
Intersecting Rural, Racial, and Medicaid-Linked Disparities in Cervical Cancer Outcomes Across North Carolina, 2019–2023
Presented by Vaidehi Mujumdar, MD, Atrium Health Levine Cancer Institute
Learn MoreAbstract #15
Friday, June 19, 2026 | 9:15 am – 9:30 am
Survivorship Experiences among Young Gynecologic Cancer Survivors: Clinical Implications for Practice
Presented by Victoria Rodriguez, PhD, MSW, MPH, University of California Los Angeles
Learn MoreAbstract #16
Friday, June 19, 2026 | 10:00 am – 10:15 am
Risk Stratification and Targeted Thromboprophylaxis in Gynecologic Oncology Patients Undergoing Chemotherapy
Presented by Sarah Moghaddam, BS, Lewis Katz School of Medicine at Temple University
Learn MoreAbstract #17
Friday, June 19, 2026 | 10:15 am – 10:30 am
Are Biosimilars as Safe? A Comparative Study of Bevacizumab in Gynecologic Cancer
Presented by Tali Pomerantz, MD, UC Davis Health
Learn MoreAbstract #18
Friday, June 19, 2026 | 10:30 am – 10:45 am
Outdoor air pollution exposure and endometrial cancer subtypes
Presented by Larissa Araujo, MD, Emory University
Learn MoreAbstract #19
Saturday, June 20, 2026 | 8:30 am – 8:45 am
ICG Use for Sentinel Lymph Node Mapping in Vulvar Cancer: A Surgical Video Demonstration
Presented by Malavika Perinchery, MD, University of Chicago
Learn MoreAbstract #20
Saturday, June 20, 2026 | 8:45 am – 9:00 am
COVID-19 mRNA vaccination improves survival in patients with endometrial cancer undergoing therapy with immune checkpoint inhibitors
Presented by Yingao Zhang, MD, MS, Cedars-Sinai
Learn MoreAbstract #21
Saturday, June 20, 2026 | 9:00 am – 9:15 am
Cancer at work: A qualitative exploration of the psychosocial impact of employment disruption among patients with recurrent ovarian cancer
Presented by Naomi Adjei, MD, MPH, University of Texas MD Anderson Cancer Center
Learn MoreAbstract #22
Saturday, June 20, 2026 | 9:15 am – 9:30 am
Gynecologic and Breast Oncology Care Patterns Among American Indian and Alaska Native Women by Social Vulnerability Index
Presented by Katherine Bolten, MD, Oregon Health and Science University
Learn More
Abstract #23
Saturday, June 20, 2026 | 9:30 am – 9:45 am
Assessment of sexual health training and clinical practice in gynecologic oncology fellowship
Presented by Grace Hohnadel, BS, Medical College of Georgia
Learn MoreAbstract #24
Saturday, June 20, 2026 | 10:05 am – 10:20 am
Postpartum HPV Vaccination Uptake: Attitudes, Beliefs, and Determinants of Acceptance
Presented by Jessica Currier, PhD, MPH, Oregon Health & Science University, Knight Cancer Institute
Learn MoreAbstract #25
Saturday, June 20, 2026 | 10:20 am – 10:35 am
ESR1 Alterations in Gynecologic Malignancies: Prevalence, Genomic Landscape, and Therapeutic Implications
Presented by Eliya Shachar, MD, University of California Los Angeles
Learn MoreAbstract #26
Saturday, June 20, 2026 | 10:35 am – 10:50 am
Combination oncolytic virotherapy and STAT3 inhibition improves long-term survival in an immunocompetent ovarian cancer murine model
Presented by Gracie Williams, MD, City of Hope National Medical Center
Learn MoreAbstract #27
Saturday, June 20, 2026 | 10:50 am – 11:05 am
Differential Effects of GPX4 Inhibitor on Drug-tolerant Persister Ovarian Cancer Cells
Presented by Katherine Jane Chua, MD, University of California Davis Health System
Learn MoreAbstract #28
Saturday, June 20, 2026 | 11:05 am – 11:20 am
Novel Hormone Receptor Positivity Cut-offs in Endometrial Cancer: A real-world Endometrial Cancer Molecularly Targeted Therapy Consortium cohort study
Presented by Jessica Benally, MD, University of New Mexico
Learn More